orchard therapeutics stock price target
Orchard Therapeutics Target Price Projection Orchard Therapeutics current and average target prices are 044 and 1500 respectively. Orchard Therapeutics stock forecast analyst price target predictions based on 1 analysts offering 12-months price targets for DEOT1A in the last 3 months.
Gene Therapy Companies Undervalued Positioned For Upside Nasdaq
The latest price target for.
. Orchard Therapeutics stock forecast analyst price target predictions based on 1 analysts offering 12-months price targets for DEOT1A in the last 3 months. On average they expect the. ORTX IEX Real-Time Price USD 0443.
Orchard Therapeutics stock forecast analyst price target predictions based on 3 analysts offering 12-months price targets for DEOT1A in the last 3 months. Evolution of the average Target Price on ORCHARD THERAPEUTICS PLC. Last 18 months Recommendations Chart ORCHARD.
Based on short-term price targets offered by four analysts the average price target for Orchard Therapeutics PLC Sponsored ADR comes to 475. The forecasts range from a low of 400 to. 6 analysts have issued 12-month price targets for Orchard Therapeutics shares.
Stock quote stock chart quotes analysis advice financials and news for share ORCHARD THERAPEUTICS PLC Deutsche Boerse AG. Orchard Therapeutics PLC ORTX NASDAQ. 03 2022 GLOBE NEWSWIRE -- Orchard.
Orchard Therapeutics started at overweight with 25 stock price target at JP. ORTX was reported by SMBC Nikko on April 1 2022The analyst firm set a price target for 000 expecting ORTX to fall to within 12. Company to host KOL conference call and webcast on Monday December 12 at 500 pm.
2 Wall Street analysts that have issued a 1 year ORTX price target the average ORTX price target is 850. Orchard Therapeutics stock forecast analyst price target predictions based on 1 analysts offering 12-months price targets for ORTX in the last 3 months. Orchard Therapeutics plc is a gene therapy company.
The current price of Orchard Therapeutics is the price. The latest price target for Orchard Therapeutics NASDAQ. BOSTON and LONDON Nov.
ET by Tomi Kilgore Orchard Therapeutics started at. The 6 analysts offering 12-month price forecasts for Orchard Therapeutics PLC have a median target of 450 with a high estimate of 500 and a low estimate of 100. The analyst firm set a price target for 400 expecting ORTX.
ORTX was reported by Barclays on Friday May 13 2022. ORCHARD THERAPEUTICS PLC FRAOT1A. The Company is engaged in development manufacturing and.
Find the latest Orchard Therapeutics plc ORTX analyst stock forecast price target and recommendation trends with in-depth analysis from research reports. According to 13 stock analysts the average 12-month. The average Orchard Therapeutics stock price prediction.
Target Price consensus revisions. 26 2018 at 714 am. Their ORTX share price forecasts range from 400 to 1300.
Find the latest Orchard Therapeutics PLC ORTX stock price forecast 12-month price target predictions and analyst recommendations.
Orchard Therapeutics Stock Nasdaq Ortx Quotes And News Summary Benzinga
Orchard Therapeutics Assumed Overweight At Cantor With 9 Target Nasdaq Ortx Seeking Alpha
Ortx Orchard Therapeutics Plc Cnnmoney Com
Orchard Therapeutics Plc Ortx Stock Price Quote News Stock Analysis
Orchard Therapeutics An Undervalued Stock With Upcoming Catalysts Nasdaq Ortx Seeking Alpha
2 Strong Buy Penny Stocks That Could Deliver Massive Returns
Orchard Therapeutics Plc Trade Ideas Nasdaq Ortx Tradingview
Buy Ortx Stock Ortx Stock Price Today News Public Com
Orchard Therapeutics Plc Ortx Stock Price Quote News Stock Analysis
Sec Filing Fulcrum Therapeutics
Orchard Therapeutics Stock Nasdaq Ortx Quotes And News Summary Benzinga
Jpmorgan Bets On These 3 Stocks Sees Over 50 Upside Potential Nasdaq
Ortx Stock Forecast Price News Orchard Therapeutics
Orchard Therapeutics Commits To Gene Therapies Production Facility With Plans To Hire 100 Workers Fierce Pharma
Orchard Therapeutics Plc American Depositary Shares Ortx Stock Price Quote News History Nasdaq
Cidara Therapeutics Nasdaqcm Cdtx Stock Price Quote Analysis Simply Wall St